APA (7th ed.) Citation

Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., . . . Ventura, C. B. (2018). Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Archives of Pathology & Laboratory Medicine, 142(3), 321. https://doi.org/10.5858/arpa.2017-0388-CP

Chicago Style (17th ed.) Citation

Lindeman, Neal I., et al. "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology." Archives of Pathology & Laboratory Medicine 142, no. 3 (2018): 321. https://doi.org/10.5858/arpa.2017-0388-CP.

MLA (9th ed.) Citation

Lindeman, Neal I., et al. "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology." Archives of Pathology & Laboratory Medicine, vol. 142, no. 3, 2018, p. 321, https://doi.org/10.5858/arpa.2017-0388-CP.